Compare SLDB & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLDB | RGR |
|---|---|---|
| Founded | 2013 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.6M | 521.9M |
| IPO Year | 2017 | 1994 |
| Metric | SLDB | RGR |
|---|---|---|
| Price | $8.33 | $42.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | $16.36 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 1.0M | 170.6K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.09% |
| EPS Growth | ★ 34.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $8,094,000.00 | ★ $546,057,000.00 |
| Revenue This Year | N/A | $2.38 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.94 |
| 52 Week Low | $2.45 | $28.33 |
| 52 Week High | $8.87 | $48.21 |
| Indicator | SLDB | RGR |
|---|---|---|
| Relative Strength Index (RSI) | 59.74 | 63.66 |
| Support Level | $5.16 | $35.42 |
| Resistance Level | $8.47 | $44.72 |
| Average True Range (ATR) | 0.62 | 1.29 |
| MACD | 0.06 | 0.05 |
| Stochastic Oscillator | 72.18 | 67.45 |
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.